BofA/Merrill Lynch Upgrades Biogen (BIIB) to Buy

April 12, 2013 9:00 AM EDT
Get Alerts BIIB Hot Sheet
Price: $292.30 --0%

Rating Summary:
    20 Buy, 13 Hold, 0 Sell

Rating Trend: Up Up

Today's Overall Ratings:
    Up: 0 | Down: 0 | New: 0
Trade BIIB Now!
Join SI Premium – FREE
BofA/Merrill Lynch upgraded Biogen (NASDAQ: BIIB) from Neutral to Buy with a price target of $246.00 (from $187.00).

For an analyst ratings summary and ratings history on Biogen click here. For more ratings news on Biogen click here.

Shares of Biogen closed at $200.26 yesterday.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories

Hot Upgrades, Upgrades

Related Entities

Merrill Lynch, Bank of America

Add Your Comment